Attached files

file filename
10-K - ARRHYTHMIA RESEARCH 2009 10K - MICRON SOLUTIONS INC /DE/art200910k.htm
EX-23.1 - EX23-1 AUDITORS CONSENT - MICRON SOLUTIONS INC /DE/exhibit23-1.htm
EX-32.2 - EX32-2 CERTIFICATION OF CFO SEC906 SOX 2002 - MICRON SOLUTIONS INC /DE/exhibit32-2.htm
EX-31.1 - EX31-1 CERTIFICATION OF CEO - MICRON SOLUTIONS INC /DE/exhibit31-1.htm
EX-31.2 - EX31-1 CERTIFICATION OF CFO - MICRON SOLUTIONS INC /DE/exhibit31-2.htm

 
 

 

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report on Form 10-K of Arrhythmia Research Technology, Inc. (the “Company”) for the year ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned President and Chief Executive Officer certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 

 
(1)  
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
(2)  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: March 10, 2010

/s/  James E. Rouse
James E. Rouse
President and
Chief Executive Officer